Skip to main content

Table 1 Quantitative assessment of body weight and select organ weight

From: Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling

OrganControlVehicle TreatedWFA (2 mg/kg)WFA (6 mg/kg)
BW (Initial) (g)18.71 ± 0.9118.96 ± 2.1119.14 ± 1.5019.60 ± 0.76
BW (final) (g)20.83 ± 1.5322.65 ± 2.0022.68 ± 2.5323.57 ± 1.23
Kidney (mg/g)6.26 ± 0.576.08 ± 1.034.95 ± 0.795.45 ± 0.49
Liver (mg/g)53.67 ± 4.6544.54 ± 3.6447.16 ± 15.8841.18 ± 3.60
Spleen (mg/g)1.41 ± 0.532.06 ± 0.112.20 ± 1.742.78 ± 1.45
Heart (mg/g)5.56 ± 1.124.20 ± 0.214.97 ± 1.963.74 ± 0.23
  1. Gross body weight was recorded for each group over the course of the study. Selected organ weights were recorded and then normalized to final body weight of corresponding mice
  2. Data displayed as x̅ ± σ. BW = Body weight